EcoDrugPlus

Akt Serine/threonine Kinase 1

Ensembl ID : ENSHHUG00000040707
Gene Symbol: AKT1
1 Cross references
181 Possible Orthologues:

Akt Serine/threonine Kinase 1

Ensembl ID : ENSHHUG00000048131
Gene Symbol: AKT1
1 Cross references
144 Possible Orthologues:

Akt Serine/threonine Kinase 1

Ensembl ID : ENSHHUG00000047301
Gene Symbol: AKT1
2 Cross references
144 Possible Orthologues:

Apex Nuclease (Multifunctional Dna Repair Enzyme) 1

Ensembl ID : ENSHHUG00000012714
Gene Symbol: APEX1
1 Cross references
209 Possible Orthologues:

Apex Nuclease (Multifunctional Dna Repair Enzyme) 1

Ensembl ID : ENSHHUG00000010336
Gene Symbol: APEX1
1 Cross references
205 Possible Orthologues:

Atp-Binding Cassette, Sub-Family C (Cftr/mrp), Member 8

Ensembl ID : ENSHHUG00000047771
Gene Symbol: ABCC8
1 Cross references
223 Possible Orthologues:

Atp-Binding Cassette, Sub-Family C (Cftr/mrp), Member 8

Ensembl ID : ENSHHUG00000010901
Gene Symbol: ABCC8
1 Cross references
223 Possible Orthologues:

Atp-Binding Cassette, Sub-Family C (Cftr/mrp), Member 9

Ensembl ID : ENSHHUG00000010878
Gene Symbol: ABCC9
1 Cross references
218 Possible Orthologues:

Atpase H+/k+ Transporting Subunit Alpha

Ensembl ID : ENSHHUG00000013193
Gene Symbol: ATP4A
2 Cross references
173 Possible Orthologues:

Atpase H+/k+ Transporting Subunit Beta

Ensembl ID : ENSHHUG00000029957
Gene Symbol: ATP4B
2 Cross references
184 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 1

Ensembl ID : ENSHHUG00000039101
Gene Symbol: ATP1A1
1 Cross references
152 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 1

Ensembl ID : ENSHHUG00000026354
Gene Symbol: ATP1A1
1 Cross references
212 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).